Nancy Valente
CIK 1891344 · EVP, Chief Development Officer · last filed 2025-05-06
Nancy Valente is an EVP, Chief Development Officer who has filed 9 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider sold $50.9K of XNCR on May 6, 2025. Across all open-market trades the lifetime net is −$197.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $606.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$606.3K
2
9
-$197.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XNCR | EVP, Chief Development Officer | 49,169 | $12.33 | $606.3K | -$197.7K | 6 | 2025-05-06 |
| Myovant Sciences Ltd. (MYOV) Delisted | Director | 0 | $26.98 | $0 | $0 | 3 | 2023-03-10 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-06 | XNCR | Sell (S) | −4,616 | -$50.9K | EDGAR |
| 2025-03-11 | XNCR | Sell (S) | −2,565 | -$34.9K | EDGAR |
| 2024-05-03 | XNCR | Sell (S) | −4,745 | -$111.9K | EDGAR |
| 2024-03-07 | XNCR | Grant (A) | +19,634 | $0 | EDGAR |
| 2023-05-03 | XNCR | Grant (A) | +39,296 | $0 | EDGAR |
| 2023-03-10 | Myovant Sciences Ltd. (MYOV) Delisted | Disp (D) | −3,673 | $0 | EDGAR |
| 2022-10-28 | Myovant Sciences Ltd. (MYOV) Delisted | Grant (A) | +9,859 | $0 | EDGAR |
| 2022-09-09 | XNCR | Grant (A) | — | $0 | EDGAR |
| 2021-11-09 | Myovant Sciences Ltd. (MYOV) Delisted | Grant (A) | — | $0 | EDGAR |